Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Investors are weighing the high probability of a Federal Reserve rate hike against concerns over surging oil prices and volatile Treasury yields, leading to cautious and bearish sentiment ahead of the FOMC decision. The conversation is further dominated by debates regarding the impact of proposed artificial intelligence development slowdowns on tech stocks.

The community is debating the potential impacts of a Federal Reserve rate hike following reports of a 90% probability of an increase, while also reacting to conflicting signals regarding artificial intelligence development and rising Treasury yields.

Iovance Biotherapeutics is trending as traders anticipate positive guidance updates and upcoming trial data, following recent healthcare conference appearances. Community sentiment remains bullish, with investors speculating on potential institutional accumulation and the company's long-term value driven by its TIL therapy platform.

AppLovin is trending as traders debate whether the stock's recent price consolidation represents institutional accumulation or manipulation, with many investors maintaining a bullish long-term outlook based on fundamental growth and free cash flow despite the lack of immediate upward momentum. While some traders expressed frustration over the stock's failure to sustain rallies and its sensitivity to interest rate concerns and analyst downgrades, others highlight strong technical indicators and upcoming holiday season e-commerce tailwinds as catalysts for a potential reversal.

TLT is trending as traders react to rising long-term Treasury yields and shifting expectations for a potential Federal Reserve rate hike. The conversation remains divided, with some investors debating whether to buy the dip in bonds while others anticipate further downside due to ongoing inflationary pressures and energy market volatility.

Gold is facing pressure as traders react to rising US Treasury yields and shifting market expectations regarding interest rate decisions, leading to a period of uncertainty. While some investors remain bullish on gold as a hedge against long-term debt concerns, many in the community are closely monitoring macro data and bond market volatility for signals on the next price trend.

Traders are intensely debating whether the asset is a viable hedge against potential market volatility or a structurally flawed "scam" designed to decay due to its reliance on VIX futures contango. Many express frustration that the instrument fails to spike meaningfully despite persistent concerns over geopolitical tensions, high interest rates, and inflation, leading to accusations of market manipulation.

Quantinuum is trending following its recent public offering and the finalization of a 100 million dollar federal funding agreement from the U.S. Department of Commerce under the CHIPS and Science Act. Traders are closely monitoring the company's valuation, commercial progress, and index inclusion prospects, with ongoing community debate regarding the relative technological merits of various quantum computing approaches.

Clover Health is trending as traders speculate on a potential strategic partnership with Humana, fueled by recent job postings and industry developments regarding the company's Counterpart Assistant platform. While retail sentiment remains overwhelmingly bullish, there is ongoing debate regarding the timeline for revenue realization and frustration over the stock's recent price consolidation despite these perceived tailwinds.

Rigetti Computing is trending as traders discuss the company's recent definitive agreement to receive up to $100 million in government funding to accelerate quantum research, a catalyst that has sparked debate over the potential for dilution versus long-term growth. The stock is also being traded in tandem with other quantum computing peers amid high volatility, with investors monitoring the company's technical milestones and insider activity.